{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:50:55Z","timestamp":1792219855656,"version":"4.4.0"},"reference-count":65,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,12,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Traditionally, hematopoietic stem cell transplantation (HSCT) from both HLA-matched related and unrelated donors (UD) has been used for treating children with acute leukemia (AL) in need of an allograft. Recently, HLA-haploidentical HSCT after \u03b1\u03b2 T-cell\/B-cell depletion (\u03b1\u03b2haplo-HSCT) was shown to be effective in single-center studies. Here, we report the first multicenter retrospective analysis of 127 matched UD (MUD), 118 mismatched UD (MMUD), and 98 \u03b1\u03b2haplo-HSCT recipients, transplanted between 2010 and 2015, in 13 Italian centers. All these AL children were transplanted in morphological remission after a myeloablative conditioning regimen. Graft failure occurred in 2% each of UD-HSCT and \u03b1\u03b2haplo-HSCT groups. In MUD vs MMUD-HSCT recipients, the cumulative incidence of grade II to IV and grade III to IV acute graft-versus-host disease (GVHD) was 35% vs 44% and 6% vs 18%, respectively, compared with 16% and 0% in \u03b1\u03b2haplo-HSCT recipients (P &amp;lt; .001). Children treated with \u03b1\u03b2haplo-HSCT also had a significantly lower incidence of overall and extensive chronic GVHD (P &amp;lt; .01). Eight (6%) MUD, 32 (28%) MMUD, and 9 (9%) \u03b1\u03b2haplo-HSCT patients died of transplant-related complications. With a median follow-up of 3.3 years, the 5-year probability of leukemia-free survival in the 3 groups was 67%, 55%, and 62%, respectively. In the 3 groups, chronic GVHD-free\/relapse-free (GRFS) probability of survival was 61%, 34%, and 58%, respectively (P &amp;lt; .001). When compared with patients given MMUD-HSCT, \u03b1\u03b2haplo-HSCT recipients had a lower cumulative incidence of nonrelapse mortality and a better GRFS (P &amp;lt; .001). These data indicate that \u03b1\u03b2haplo-HSCT is a suitable therapeutic option for children with AL in need of transplantation, especially when an allele-matched UD is not available.<\/jats:p>","DOI":"10.1182\/blood-2018-07-861575","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T14:15:24Z","timestamp":1540217724000},"page":"2594-2607","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":131,"title":["Unrelated donor vs HLA-haploidentical \u03b1\/\u03b2 T-cell\u2013 and B-cell\u2013depleted HSCT in children with acute leukemia"],"prefix":"10.1182","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3729-436X","authenticated-orcid":false,"given":"Alice","family":"Bertaina","sequence":"first","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology and Cell and Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Ospedale Bambino Ges\u00f9, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zecca","sequence":"first","affiliation":[{"name":"Pediatric Hematology\/Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Buldini","sequence":"first","affiliation":[{"name":"Pediatric Hematology-Oncology Unit, Department of Women's and Children's Health, Azienda Ospedaliera-University of Padova, Padova, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Sacchi","sequence":"first","affiliation":[{"name":"Struttura Complessa Laboratorio di Istocompatibilit\u00e0\/Italian Registry of Bone Marrow Donors, Ente Ospedaliero Ospedali Galliera, Genoa, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Algeri","sequence":"first","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology and Cell and Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Ospedale Bambino Ges\u00f9, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Saglio","sequence":"first","affiliation":[{"name":"Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, Torino, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Perotti","sequence":"first","affiliation":[{"name":"Immunohaematology and Transfusion Service, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Gallina","sequence":"first","affiliation":[{"name":"Struttura Complessa Laboratorio di Istocompatibilit\u00e0\/Italian Registry of Bone Marrow Donors, Ente Ospedaliero Ospedali Galliera, Genoa, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9028-7767","authenticated-orcid":false,"given":"Valentina","family":"Bertaina","sequence":"first","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology and Cell and Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Ospedale Bambino Ges\u00f9, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Lanino","sequence":"first","affiliation":[{"name":"Hematopoietic Stem Cell Unit, Department of Hematology-Oncology, Istituto G. Gaslini, Genova, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arcangelo","family":"Prete","sequence":"first","affiliation":[{"name":"Oncology, Hematology and Hematopoietic Stem Cell Transplant Program, Unita' operativa Pediatrics- S. Orsola-Malpighi University of Bologna, Bologna, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Barberi","sequence":"first","affiliation":[{"name":"Department of Hematology, Azienda Policlinico Umberto I, Sapienza University of Rome, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Tumino","sequence":"first","affiliation":[{"name":"Pediatric Hematology-Oncology Unit, Department of Women's and Children's Health, Azienda Ospedaliera-University of Padova, Padova, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Favre","sequence":"first","affiliation":[{"name":"Transplantation Unit, Department of Pediatric Oncology, Meyer Children's Hospital, Florence, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Cesaro","sequence":"first","affiliation":[{"name":"Pediatric Hematology Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Del Bufalo","sequence":"first","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology and Cell and Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Ospedale Bambino Ges\u00f9, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimmo","family":"Ripaldi","sequence":"first","affiliation":[{"name":"Department of Hemato-Oncology, Santobono-Pausilipon Hospital, Bone Marrow Transplant Unit, Napoli, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Boghen","sequence":"first","affiliation":[{"name":"Pediatric Hematology\/Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;"},{"name":"Cell Factory, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Casazza","sequence":"first","affiliation":[{"name":"Pediatric Onco-Hematology, Azienda Ospedaliera\/Universitaria Pisana, Pisa, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Rabusin","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Institute of Maternal and Child Health, IRCCS Burlo Garofolo Trieste, Trieste, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Balduzzi","sequence":"first","affiliation":[{"name":"Bone Marrow Transplantation Unit, Pediatric Department of Milano-Bicocca University, Monza e Brianza per il Bambino e la sua Mamma Foundation, Monza, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Fagioli","sequence":"first","affiliation":[{"name":"Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, Torino, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Pagliara","sequence":"first","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology and Cell and Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Ospedale Bambino Ges\u00f9, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"first","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology and Cell and Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Ospedale Bambino Ges\u00f9, Rome, Italy;"},{"name":"Department of Pediatric Sciences, University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"17","key":"2020071008503514200_B1","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"2020071008503514200_B2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.bmt.1705963","article-title":"Searching for alternative hematopoietic stem cell donors for pediatric patients","volume":"41","author":"Rocha","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2020071008503514200_B3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"2020071008503514200_B4","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbmt.2006.05.011","article-title":"Cord blood transplantation","volume":"12","author":"Gluckman","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2020071008503514200_B5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2141.2009.07783.x","article-title":"Improving cord blood transplantation in children","volume":"147","author":"Locatelli","year":"2009","journal-title":"Br J Haematol"},{"issue":"3","key":"2020071008503514200_B6","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/sj.leu.2402382","article-title":"Haploidentical \u2018megadose\u2019 CD34+ cell transplants for patients with acute leukemia","volume":"16","author":"Martelli","year":"2002","journal-title":"Leukemia"},{"key":"2020071008503514200_B7","article-title":"Graft-versus-host disease","author":"Ferrara"},{"issue":"4","key":"2020071008503514200_B8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.beha.2017.09.003","article-title":"Which factors influence the development of GVHD in HLA-matched or mismatched transplants?","volume":"30","author":"Petersdorf","year":"2017","journal-title":"Best Pract Res Clin Haematol"},{"issue":"5","key":"2020071008503514200_B9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1182\/blood-2014-06-579714","article-title":"Haplo is the new black","volume":"124","author":"Pulsipher","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2020071008503514200_B10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11899-017-0364-3","article-title":"T cell-depleted and T cell-replete HLA-haploidentical stem cell transplantation for non-malignant disorders","volume":"12","author":"Bertaina","year":"2017","journal-title":"Curr Hematol Malig Rep"},{"key":"2020071008503514200_B11","doi-asserted-by":"crossref","article-title":"Haploidentical hematopoietic transplantation: current status and future perspectives","author":"Reisner","DOI":"10.1182\/blood-2011-07-338822"},{"issue":"4","key":"2020071008503514200_B12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1053\/j.seminhematol.2016.07.001","article-title":"Haploidentical transplants using ex vivo T-cell depletion","volume":"53","author":"Martelli","year":"2016","journal-title":"Semin Hematol"},{"issue":"17","key":"2020071008503514200_B13","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"N Engl J Med"},{"issue":"11","key":"2020071008503514200_B14","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1182\/blood.V84.11.3948.bloodjournal84113948","article-title":"Successful engraftment of T-cell-depleted haploidentical \u201cthree-loci\u201d incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum","volume":"84","author":"Aversa","year":"1994","journal-title":"Blood"},{"issue":"8","key":"2020071008503514200_B15","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1080\/14653240701644000","article-title":"A large-scale method for the selective depletion of alphabeta T lymphocytes from PBSC for allogeneic transplantation","volume":"9","author":"Chaleff","year":"2007","journal-title":"Cytotherapy"},{"issue":"1-2","key":"2020071008503514200_B16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.imlet.2013.09.027","article-title":"Negative depletion of \u03b1\/\u03b2+ T cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation","volume":"155","author":"Locatelli","year":"2013","journal-title":"Immunol Lett"},{"key":"2020071008503514200_B17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fimmu.2013.00015","article-title":"Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells","volume":"4","author":"Locatelli","year":"2013","journal-title":"Front Immunol"},{"key":"2020071008503514200_B18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.imlet.2016.05.007","article-title":"Human NK cells: From surface receptors to clinical applications","volume":"178","author":"Moretta","year":"2016","journal-title":"Immunol Lett"},{"issue":"2","key":"2020071008503514200_B19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.smim.2014.02.004","article-title":"Natural killer cells in the treatment of high-risk acute leukaemia","volume":"26","author":"Locatelli","year":"2014","journal-title":"Semin Immunol"},{"key":"2020071008503514200_B20","volume-title":"Blood","author":"Airoldi","year":"2015"},{"issue":"5","key":"2020071008503514200_B21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1089\/scd.1.1996.5.503","article-title":"Increased frequency of TCR gamma delta + T cells in disease-free survivors following T cell-depleted, partially mismatched, related donor bone marrow transplantation for leukemia","volume":"5","author":"Lamb","year":"1996","journal-title":"J Hematother"},{"issue":"5","key":"2020071008503514200_B22","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2014-03-563817","article-title":"HLA-haploidentical stem cell transplantation after removal of \u03b1\u03b2+ T and B cells in children with nonmalignant disorders","volume":"124","author":"Bertaina","year":"2014","journal-title":"Blood"},{"issue":"suppl 2","key":"2020071008503514200_B23","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/bmt.2015.87","article-title":"Improved immune recovery after transplantation of TCR\u03b1\u03b2\/CD19-depleted allografts from haploidentical donors in pediatric patients","volume":"50","author":"Lang","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"2020071008503514200_B24","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/bmt.2015.343","article-title":"TCR-alpha\/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia","volume":"51","author":"Maschan","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"2020071008503514200_B25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood-2017-04-779769","article-title":"Outcome of children with acute leukemia given HLA-haploidentical HSCT after \u03b1\u03b2 T-cell and B-cell depletion","volume":"130","author":"Locatelli","year":"2017","journal-title":"Blood"},{"issue":"1","key":"2020071008503514200_B26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/blood-2006-07-038687","article-title":"Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value","volume":"110","author":"Ruggeri","year":"2007","journal-title":"Blood"},{"issue":"13","key":"2020071008503514200_B27","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1182\/blood-2008-06-164103","article-title":"Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity","volume":"113","author":"Pende","year":"2009","journal-title":"Blood"},{"issue":"17","key":"2020071008503514200_B28","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1182\/blood-2014-03-565069","article-title":"KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL","volume":"124","author":"Oevermann","year":"2014","journal-title":"Blood"},{"issue":"14","key":"2020071008503514200_B29","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood-2010-05-283051","article-title":"Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia","volume":"116","author":"Cooley","year":"2010","journal-title":"Blood"},{"issue":"6","key":"2020071008503514200_B30","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/eji.201546236","article-title":"Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1\/S1","volume":"46","author":"Alicata","year":"2016","journal-title":"Eur J Immunol"},{"issue":"3","key":"2020071008503514200_B31","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1182\/blood-2010-08-264085","article-title":"Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation","volume":"117","author":"Moretta","year":"2011","journal-title":"Blood"},{"issue":"13","key":"2020071008503514200_B32","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1182\/blood-2008-06-164103","article-title":"Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity","volume":"113","author":"Pende","year":"2009","journal-title":"Blood"},{"issue":"1","key":"2020071008503514200_B33","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12967-014-0240-z","article-title":"Mobilization of healthy donors with plerixafor affects the cellular composition of T-cell receptor (TCR)-\u03b1\u03b2\/CD19-depleted haploidentical stem cell grafts","volume":"12","author":"Rutella","year":"2014","journal-title":"J Transl Med"},{"issue":"11","key":"2020071008503514200_B34","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.bbmt.2016.08.006","article-title":"Selective depletion of \u03b1\u03b2 T cells and B cells for human leukocyte antigen-haploidentical hematopoietic stem cell transplantation. a three-year follow-up of procedure efficiency","volume":"22","author":"Li Pira","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2020071008503514200_B35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"issue":"4","key":"2020071008503514200_B36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/bbmt.2003.50026","article-title":"Chronic graft-versus-host disease","volume":"9","author":"Lee","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"2020071008503514200_B37","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1182\/blood-2014-10-609032","article-title":"Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation","volume":"125","author":"Holtan","year":"2015","journal-title":"Blood"},{"issue":"282","key":"2020071008503514200_B38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc."},{"issue":"10","key":"2020071008503514200_B39","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.bmt.1703260","article-title":"Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis","volume":"28","author":"Klein","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"2020071008503514200_B40","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.bmt.1703271","article-title":"Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling","volume":"28","author":"Klein","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2020071008503514200_B41","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"issue":"6","key":"2020071008503514200_B42","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/s41409-018-0126-4","article-title":"Comparison of outcomes following transplantation with T-replete HLA-haploidentical donors using post-transplant cyclophosphamide to matched related and unrelated donors for patients with AML and MDS aged 60 years or older","volume":"53","author":"Bashey","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"2020071008503514200_B43","author":"Sestili"},{"issue":"7","key":"2020071008503514200_B44","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.bbmt.2018.02.002","article-title":"HLA-matched sibling versus unrelated versus haploidentical related donor allogeneic hematopoietic stem cell transplantation for patients aged over 60 years with acute myeloid leukemia: a single-center donor comparison","volume":"24","author":"Devillier","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"13","key":"2020071008503514200_B45","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1182\/blood-2009-01-200527","article-title":"Rituximab reduces the incidence of acute graft-versus-host disease","volume":"113","author":"Christopeit","year":"2009","journal-title":"Blood"},{"issue":"23","key":"2020071008503514200_B46","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1182\/blood-2016-07-730564","article-title":"Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation","volume":"128","author":"Mancusi","year":"2016","journal-title":"Blood"},{"issue":"2","key":"2020071008503514200_B47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MOH.0000000000000412","article-title":"Have haploidentical transplants replaced umbilical cord transplants for acute leukemias?","volume":"25","author":"Liu","year":"2018","journal-title":"Curr Opin Hematol"},{"issue":"5","key":"2020071008503514200_B48","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/bjh.12810","article-title":"Transplantation of CD3\/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia","volume":"165","author":"Lang","year":"2014","journal-title":"Br J Haematol"},{"issue":"9","key":"2020071008503514200_B49","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1111\/trf.13694","article-title":"Optimization of individualized graft composition: CD3\/CD19 depletion combined with CD34 selection for haploidentical transplantation","volume":"56","author":"Huenecke","year":"2016","journal-title":"Transfusion"},{"issue":"1","key":"2020071008503514200_B50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bcmd.2007.07.001","article-title":"Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3\/CD19 depletion and reduced intensity conditioning: an update","volume":"40","author":"Bethge","year":"2008","journal-title":"Blood Cells Mol Dis"},{"issue":"3","key":"2020071008503514200_B51","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00007890-198709000-00002","article-title":"T cell subsets and graft-versus-host disease","volume":"44","author":"Korngold","year":"1987","journal-title":"Transplantation"},{"issue":"5","key":"2020071008503514200_B52","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nri2000","article-title":"Graft-versus-host disease","volume":"7","author":"Shlomchik","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"2020071008503514200_B53","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1182\/blood-2017-08-752162","article-title":"The potential role of \u03b3\u03b4 T cells after allogeneic HCT for leukemia","volume":"131","author":"Handgretinger","year":"2018","journal-title":"Blood"},{"issue":"7","key":"2020071008503514200_B54","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nri2781","article-title":"Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity","volume":"10","author":"Bonneville","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"2020071008503514200_B55","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/sj.bmt.1703043","article-title":"TCR gamma delta cytotoxic T lymphocytes expressing the killer cell-inhibitory receptor p58.2 (CD158b) selectively lyse acute myeloid leukemia cells","volume":"27","author":"Dolstra","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"2020071008503514200_B56","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.bmt.1705650","article-title":"Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation","volume":"39","author":"Godder","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2020071008503514200_B57","doi-asserted-by":"crossref","first-page":"e1216291","DOI":"10.1080\/2162402X.2016.1216291","article-title":"Zoledronic acid boosts \u03b3\u03b4 T-cell activity in children receiving \u03b1\u03b2+ T and CD19+ cell-depleted grafts from an HLA-haplo-identical donor","volume":"6","author":"Bertaina","year":"2016","journal-title":"OncoImmunology"},{"issue":"5","key":"2020071008503514200_B58","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/bjh.15086","article-title":"Pre- and post-transplant minimal residual disease predicts relapse occurrence in children with acute lymphoblastic leukaemia","volume":"180","author":"Lovisa","year":"2018","journal-title":"Br J Haematol"},{"issue":"11","key":"2020071008503514200_B59","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2014.58.4631","article-title":"Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial","volume":"33","author":"Bader","year":"2015","journal-title":"J Clin Oncol"},{"issue":"7","key":"2020071008503514200_B60","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.bbmt.2017.03.017","article-title":"Multicolor flow cytometry and multigene next-generation sequencing are complementary and highly predictive for relapse in acute myeloid leukemia after allogeneic transplantation","volume":"23","author":"Getta","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"2020071008503514200_B61","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/bmt.2017.16","article-title":"Next-generation sequencing indicates false-positive MRD results and better predicts prognosis after SCT in patients with childhood ALL","volume":"52","author":"Kotrova","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"16","key":"2020071008503514200_B62","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1182\/blood-2009-11-251595","article-title":"High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease","volume":"115","author":"Luznik","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2020071008503514200_B63","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.bbmt.2016.02.002","article-title":"Feasibility and outcome of haploidentical hematopoietic stem cell transplantation with post-transplant high-dose cyclophosphamide for children and adolescents with hematologic malignancies: an AIEOP-GITMO retrospective multicenter study","volume":"22","author":"Berger","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2020071008503514200_B64","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bbmt.2016.11.016","article-title":"Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies","volume":"23","author":"Klein","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1-3","key":"2020071008503514200_B65","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12026-009-8139-0","article-title":"High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation","volume":"47","author":"Luznik","year":"2010","journal-title":"Immunol Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/132\/24\/2594\/1746896\/blood861575.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/132\/24\/2594\/1746896\/blood861575.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T08:52:04Z","timestamp":1594371124000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/132\/24\/2594\/39545\/Unrelated-donor-vs-HLAhaploidentical-%CE%B1%CE%B2-Tcell-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,13]]},"references-count":65,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2018,12,13]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2018-07-861575","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734280150.793554692","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,13]]}}}